A groundbreaking new classification, Type 5 diabetes, is emerging from decades of overlooked cases. Researchers urge formal recognition to improve treatment and understanding of this malnutrition-linked condition affecting millions.
A 47-year-old man shares his struggle with erectile dysfunction and anorgasmia, prompting concerns about his wife's feelings. Explore advice on enhancing intimacy and communication in their marriage.
An eight-year study reveals alarming links between artificial sweeteners and memory decline in middle-aged adults. Find out which sweeteners are most concerning and what it means for your health.
The World Health Organization has released its updated Essential Medicines Lists, adding crucial cancer and diabetes treatments, aiming to improve global health access.
Discover powerful yet simple daily habits that can significantly enhance your diabetes management. From eating your veggies first to mindful breathing techniques, these expert tips will help you maintain better blood sugar levels and overall health.
A groundbreaking study reveals that combining the Mediterranean diet with calorie reduction and exercise can reduce the risk of Type 2 diabetes by 31%. Learn how these lifestyle changes can transform your health!
A groundbreaking study reveals that adopting a Mediterranean diet, reducing calories, and engaging in moderate exercise can lower type 2 diabetes risk by 31%. Discover how simple lifestyle changes can save millions from this global epidemic.
In a candid discussion, celebrities share their experiences with Ozempic and other weight loss medications, revealing surprising truths, struggles, and the societal pressures surrounding body image.
In a day marked by significant market movements, EchoStar's stock skyrocketed following AT&T's $23 billion purchase of wireless licenses. Eli Lilly also saw gains with promising diabetes drug results, while Nvidia's upcoming report looms large.
Lilly's new oral pill, Orforglipron, has shown promising results in reducing weight and improving blood sugar levels in diabetes patients. With nearly 4% rise in shares, the drug is on track for FDA approval.
